CHARACTERIZATION OF ANTISENSE OLIGONUCLEOTIDES

被引：0
|
作者：
AGRAWAL, S [1 ]
机构：
[1] HYBRIDON INC,WORCESTER,MA 01605
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 1994年 / 208卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
引用
收藏
页码：153 / ANYL
相关论文
共 50 条
  • [31] Antisense oligonucleotides for the treatment of dyslipidaemia
    Visser, Maartje E.
    Witztum, Joseph L.
    Stroes, Erik S. G.
    Kastelein, John J. P.
    [J]. EUROPEAN HEART JOURNAL, 2012, 33 (12) : 1451 - 1458
  • [32] MEETING REPORT - ANTISENSE OLIGONUCLEOTIDES
    MARTINELLI, G
    FERRARI, S
    [J]. HAEMATOLOGICA, 1994, 79 (02) : 184 - 188
  • [33] Molecular Mechanisms of Antisense Oligonucleotides
    Crooke, Stanley T.
    [J]. NUCLEIC ACID THERAPEUTICS, 2017, 27 (02) : 70 - 77
  • [34] IMMUNOMODULATION BY CYTOKINE ANTISENSE OLIGONUCLEOTIDES
    DHELLENCOURT, CL
    DIAW, L
    GUENOUNOU, M
    [J]. EUROPEAN CYTOKINE NETWORK, 1995, 6 (01) : 7 - 19
  • [35] Antisense Oligonucleotides Targeting Lipoprotein(a)
    Langsted, Anne
    Nordestgaard, Borge G.
    [J]. CURRENT ATHEROSCLEROSIS REPORTS, 2019, 21 (08)
  • [36] Antisense oligonucleotides for atherosclerotic disease
    Bajaj, Archna
    Rader, Daniel J.
    [J]. NATURE MEDICINE, 2020, 26 (04) : 471 - 472
  • [37] The disposition (ADME) of antisense oligonucleotides
    Dvorchik, BH
    [J]. CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2000, 2 (03) : 253 - 257
  • [38] Antisense oligonucleotides as therapeutic agents
    Alama, A
    Barbieri, F
    Cagnoli, M
    Schettini, G
    [J]. PHARMACOLOGICAL RESEARCH, 1997, 36 (03) : 171 - 178
  • [39] Cellular delivery of antisense oligonucleotides
    Lebedeva, I
    Benimetskaya, L
    Stein, CA
    Vilenchik, M
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2000, 50 (01) : 101 - 119
  • [40] THE SENSE OF ANTISENSE FOS OLIGONUCLEOTIDES
    SHARP, FR
    [J]. ANNALS OF NEUROLOGY, 1994, 36 (04) : 555 - 556
12345